Undercover Agent (itch) Mac OS

PROGRAM OVERVIEW

Dying Light Mac OS X is now free and available for your Mac computer. It can be played as a single-player or multiplayer and has been published by Warner Bros and Interactive Entertainment. If you don’t know yet, Dying Light it’s a survival game where you are the main character, an undercover agent in a city called Harran.

Although moderate-to-severe atopic dermatitis (AD) manifests on the skin’s surface, it’s far from superficial. It’s a disease that originates from the deepest interior of the immune system to profoundly destabilize all psychophysical aspects of health-related quality of life. As the pathophysiology of AD began to unravel, it became clear that to be effective, treatment needs to target the proinflammatory pathways and cytokines that are the pruritogenic core of this disease. This program will review current and emerging monoclonal antibodies (mAbs) for the treatment of atopic dermatitis.

Find games for macOS tagged First-Person like Dying of Thirst, The Hospital, What Lives Below, Kept Hidden, fps game demo thing 3 on itch.io, the indie game hosting marketplace.
To go 'undercover' is to avoid detection by the entity one is observing, and especially to disguise one's own identity or use an assumed identity for the purposes of gaining the trust of an individual or organization to learn or confirm confidential information or to gain the trust of targeted individuals in order to gather information or evidence. Traditionally, it is a technique employed by law enforcement.

FACULTY

Seemal R. Desai, MD
Clinical Assistant Professor of Dermatology
University of Texas Southwestern
Plano, Texas

FACULTY REVIEWER

Jonathan I. Silverberg, MD, PhD, MPH
Associate Professor of Dermatology
Director, Clinical Research & Contact Dermatitis
School of Medicine and Health Sciences
The George Washington University
Washington, District of Columbia

Release date: September 16, 2020
Expiration date: September 16, 2021
Estimated time to complete activity: 0.25 hour(s)

SUPPORTER ACKNOWLEDGEMENT

Supported by an educational grant from Pfizer, Inc.

TARGET AUDIENCE

This program is intended for allergists, immunologists, dermatologists, specialty advanced practice providers, and other healthcare professionals involved in the management and treatment of patients with moderate-to-severe AD.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

Devise a strategy to incorporate emerging biologic mAbs and Janus kinsaise (JAK) inhibitors into treatment plans as they become available to appropriately selected patients with moderate-to-severe AD
Interpret endpoint results from phase 3 clinical trials comparing the biologic dupilumab with JAK inhibitors

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of September 16, 2020 through September 16, 2021, participants must:

Read the CME information (this page)
Complete the pretest
Study the educational Tweetorial/activity
Complete the posttest and the evaluation form

A statement of credit will be available for immediate download upon completion of the activity evaluation form and a completed post-test with a score of 100%

MEDIA

Internet

ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited with commendation by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity Continuing Education, Inc. designates this other activity Twitter-based Tweetorial for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or info@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported the financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Seemal R. Desai, MD does not have any conflicts of interest to disclose.

Jonathan I. Silverberg, MD, PhD, MPH
Consulting Fees: AbbVie, Arena, Asana, Bluefin, Boehringer Ingelheim, Celgene, Dermavant, Dermira, Eli Lilly, Kiniksa, Leo, Luna, Medimmune, Menlo, Novartis, Pfizer Inc., Regeneron, Sanofi Genzyme
Speakers’ Bureaus: Regeneron, Sanofi Genzyme
Contracted Research: Galderma, GlaxoSmithKline

The Integrity Continuing Education, Inc. planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Firefox 2
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10

Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Firefox 2
Flash Player 10
Use of Internet Explorer browser is not recommended.

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

PROVIDER STATEMENT

Provided by Integrity Continuing Education, Inc.

A downloadable game for Windows, macOS, and Linux

Tom-Catch is a classic third person shooter game. It was created for Ludum Dare 32 game jam event.

It tells the story of a conflict between cats and mice. The protagonist is Felician Squeakypants, who's a dead serious bad-ass agent. Professor Quincy asks him to deliver some blueprints of a secret weapon. Unfortunately these blueprints got stolen by Orlando Whiskey, a Cat agent. Now Felician has to chase him, and take back a papers.